GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eusol Biotech Co Ltd (ROCO:6652) » Definitions » 5-Year Sortino Ratio

Eusol Biotech Co (ROCO:6652) 5-Year Sortino Ratio : 0.05 (As of Jul. 23, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Eusol Biotech Co 5-Year Sortino Ratio?

The 5-Year Sortino Ratio measures the additional return that an investor receives per unit of the downside risk over the past five years. As of today (2025-07-23), Eusol Biotech Co's 5-Year Sortino Ratio is 0.05.


Competitive Comparison of Eusol Biotech Co's 5-Year Sortino Ratio

For the Biotechnology subindustry, Eusol Biotech Co's 5-Year Sortino Ratio, along with its competitors' market caps and 5-Year Sortino Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eusol Biotech Co's 5-Year Sortino Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eusol Biotech Co's 5-Year Sortino Ratio distribution charts can be found below:

* The bar in red indicates where Eusol Biotech Co's 5-Year Sortino Ratio falls into.


;
;

Eusol Biotech Co 5-Year Sortino Ratio Calculation

The 5-Year Sortino Ratio measures the risk-adjusted return of an investment asset or portfolio in the last five year, focusing specifically on downside risk rather than total risk. A stock / portfolio's 5-Year Sortino Ratio can be calculated by dividing the difference between the five-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the downside risks over the past five year.

A downside risk is a potential loss from the asset or investment. The Downside risk here is measured by the downside deviation, which is the standard deviation of negative returns.


Eusol Biotech Co  (ROCO:6652) 5-Year Sortino Ratio Explanation

The 5-Year Sortino Ratio inidicates the risk-adjusted return of an investment over the past five year. It is calculated as the annualized result of the average five-year monthly excess returns divided by the standard deviation of negative returns in the five-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

Differnt from the Sharpe Ratio that penalizes both upside and downside volatility equally, the Sortino Ratio penalizes only those returns falling below a user-specified target or required rate of return. The expected returns here is set to the risk-free rate as well.


Eusol Biotech Co 5-Year Sortino Ratio Related Terms

Thank you for viewing the detailed overview of Eusol Biotech Co's 5-Year Sortino Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eusol Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No.135, Section 3, Minsheng East Road, 6th Floor, Songshan District, Taipei, TWN, 10546
Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.

Eusol Biotech Co Headlines

No Headlines